Systemic therapies for psoriatic disease and serious adverse events in older adults: a population-based cohort study

No abstract available.

Information

Citation

Drucker AM, Sutradhar R, Ling V, Eder L, Gomes T, Fralick M, Iskandar RJ, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. J Invest Dermatol. 2025; S0022-202X(25)03528-6. Epub 2025 Nov 15.

View Source

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

09/03/2026

Comparative effectiveness of buprenorphine-naloxone and methadone for opioid overdose among youths

Kleinman RA, Larney S, Sule NO, Ma C, Szatmari P, Kurdyak P. JAMA Pediatr. 2026; Mar 9 [Epub ahead of print].

Journal Article

09/03/2026

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents

Wang TF, Clarke A, Rath M, Yoo S, Fremont D, Wu C, Ravani P, Bossé D, Talarico R, Carrier M, Sood MM. Cancer. 2026; 132(6):e70266.

Journal Article

09/03/2026

Patterns of prescription stimulant initiation before and during the COVID-19 pandemic: a population-based time series analysis

Gomes T, Wang T, Rebić N, Miller S, Paolozza L, Vigod SN, Tadrous M. CMAJ. 2026; 198(9): E313-E325.

See All